Drew Weissman to RNA, Messenger
This is a "connection" page, showing publications Drew Weissman has written about RNA, Messenger.
Connection Strength
1.679
-
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies. Nat Commun. 2018 08 22; 9(1):3361.
Score: 0.266
-
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018 06 04; 215(6):1571-1588.
Score: 0.261
-
mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018 04; 17(4):261-279.
Score: 0.255
-
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017 03 02; 8:14630.
Score: 0.240
-
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017 03 09; 543(7644):248-251.
Score: 0.239
-
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun Biol. 2021 08 11; 4(1):956.
Score: 0.082
-
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA. J Am Chem Soc. 2021 08 11; 143(31):12315-12327.
Score: 0.082
-
Highly efficient CD4+ TÂ cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Mol Ther. 2021 11 03; 29(11):3293-3304.
Score: 0.081
-
Development of vaccines and antivirals for combating viral pandemics. Nat Biomed Eng. 2020 12; 4(12):1128-1133.
Score: 0.078
-
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 10 13; 53(4):724-732.e7.
Score: 0.076
-
mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021 11; 20(11):817-838.
Score: 0.020